Schonfeld Strategic Advisors LLC Altimmune, Inc. Transaction History

Schonfeld Strategic Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.91 - $10.23 $465,046 - $804,978	-78,688 Reduced 77.58%	22,738 $151,000
Q1 2024 May 15, 2024	SELL	$8.22 - $13.81 $275,978 - $463,656	-33,574 Reduced 24.87%	101,426 $1.03 Million
Q4 2023 Feb 14, 2024	BUY	$2.14 - $11.62 $288,900 - $1.57 Million	135,000 New	135,000 $1.52 Million
Q2 2023 Aug 14, 2023	SELL	$3.45 - $5.97 $711,876 - $1.23 Million	-206,341 Reduced 75.19%	68,100 $240,000
Q1 2023 May 15, 2023	BUY	$4.19 - $16.83 $1.15 Million - $4.62 Million	274,441 New	274,441 $1.16 Million
Q3 2022 Nov 14, 2022	SELL	$10.67 - $22.41 $1.29 Million - $2.71 Million	-120,898 Reduced 67.54%	58,102 $742,000
Q2 2022 Aug 15, 2022	BUY	$3.94 - $11.77 $640,250 - $1.91 Million	162,500 Added 984.85%	179,000 $2.09 Million
Q1 2022 May 16, 2022	SELL	$5.9 - $9.45 $8,260 - $13,229	-1,400 Reduced 7.82%	16,500 $101,000
Q4 2021 Feb 14, 2022	SELL	$8.69 - $12.48 $423,203 - $607,776	-48,700 Reduced 73.12%	17,900 $164,000
Q3 2021 Nov 16, 2021	BUY	$8.43 - $16.81 $561,438 - $1.12 Million	66,600 New	66,600 $754,000
Q2 2021 Aug 16, 2021	SELL	$9.85 - $16.46 $983,364 - $1.64 Million	-99,834 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$12.71 - $24.31 $1.27 Million - $2.43 Million	99,834 New	99,834 $1.41 Million
Q3 2020 Nov 16, 2020	SELL	$9.93 - $33.26 $346,557 - $1.16 Million	-34,900 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.9 - $10.71 $101,210 - $373,779	34,900 New	34,900 $374,000

186

39.3M

913K

743K

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $404M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.